✦ LIBER ✦

Ibritumomab tiuxetan Y-90 receives priority review.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

90Y Ibritumomab Tiuxetan

✍ Christopher I. Carswell, Lynda R. Wiseman 📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 134 KB

90Y Ibritumomab Tiuxetan

✍ Ted Wun 📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 37 KB

90Y Ibritumomab Tiuxetan

✍ Nozomi Niitsu 📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 36 KB

Ibritumomab tiuxetan Y-90

📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 127 KB

Ibritumomab tiuxetan Y 90/rituximab

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 219 KB

Ibritumomab tiuxetan Y-90 consolidation

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB